Bank of New York Mellon Corp boosted its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 7.5% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 174,836 shares of the company’s stock after buying an additional 12,225 shares during the quarter. Bank of New York Mellon Corp’s holdings in U.S. Physical Therapy were worth $14,164,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the business. BlackRock Inc. raised its position in U.S. Physical Therapy by 2.1% in the 1st quarter. BlackRock Inc. now owns 2,205,096 shares of the company’s stock worth $152,150,000 after buying an additional 45,412 shares during the last quarter. Fred Alger Management LLC grew its stake in shares of U.S. Physical Therapy by 18.7% during the 1st quarter. Fred Alger Management LLC now owns 526,440 shares of the company’s stock valued at $36,324,000 after purchasing an additional 82,903 shares during the period. State Street Corp grew its stake in shares of U.S. Physical Therapy by 9.0% during the 1st quarter. State Street Corp now owns 435,774 shares of the company’s stock valued at $30,204,000 after purchasing an additional 35,909 shares during the period. Boston Trust Walden Corp grew its stake in shares of U.S. Physical Therapy by 130.6% during the 2nd quarter. Boston Trust Walden Corp now owns 307,439 shares of the company’s stock valued at $24,908,000 after purchasing an additional 174,119 shares during the period. Finally, Wasatch Advisors Inc. bought a new stake in shares of U.S. Physical Therapy during the 1st quarter valued at about $20,072,000.

In other news, CFO Lawrance W. Mcafee sold 4,450 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $91.41, for a total transaction of $406,774.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, COO Graham D. Reeve sold 1,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $90.21, for a total value of $135,315.00. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by insiders.

A number of brokerages recently issued reports on USPH. Barrington Research boosted their price objective on U.S. Physical Therapy from $95.00 to $100.00 and gave the company an “outperform” rating in a research note on Friday, August 7th. Zacks Investment Research upgraded U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $100.00 price objective for the company in a research note on Saturday, August 8th. Finally, ValuEngine downgraded U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Tuesday, September 1st. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $93.33.

NYSE USPH opened at $92.56 on Wednesday. The stock’s 50 day moving average is $88.96 and its 200 day moving average is $79.59. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.13. U.S. Physical Therapy, Inc. has a 12 month low of $45.13 and a 12 month high of $148.48. The stock has a market cap of $1.19 billion, a PE ratio of 38.57, a P/E/G ratio of 4.17 and a beta of 1.22.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.85 EPS for the quarter, topping the Zacks’ consensus estimate of ($0.18) by $1.03. U.S. Physical Therapy had a return on equity of 13.36% and a net margin of 6.64%. The company had revenue of $83.86 million for the quarter, compared to analysts’ expectations of $87.24 million. During the same period in the previous year, the firm earned $0.81 EPS. The firm’s revenue was down 33.6% compared to the same quarter last year. On average, analysts forecast that U.S. Physical Therapy, Inc. will post 1.82 EPS for the current fiscal year.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Recommended Story: How to calculate the annual rate of depreciation

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.